Intelligence · Clinical Development
Pipeline search results
Programs matching “temozolomide” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 14 pipeline programs matching "temozolomide" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Temozolomide
Adaptive Biotechnologies Corp
Glioblastoma
1 trial -
Temozolomide
GT Biopharma
Glioblastoma
1 trial -
Fibromun, Temozolomide SUN 100 mg hard capsules
Philogen S.p.A.
Glioblastoma
1 trial -
Radiotherapy plus temozolomide
The First People's Hospital of Lianyungang
Glioma (Any Grade) in the Brain
1 trial -
TEMOZOLOMIDE
The George Institute
Diffuse low-grade gliomas
1 trial -
TEMOZOLOMIDE
Istituto Gentili S.r.l.
Patients with well differentiated neuroendocrine neoplasia (NENs) not eligible for active antitumoral treatments due to their clinical conditions.
1 trial -
TEMOZOLOMIDE , IRINOTECAN
Fondazione Telethon ETS
Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy
1 trial -
TEMOZOLOMIDE for locally advanced rectal cancer (LARC)
Fondazione Telethon ETS
locally advanced rectal cancer (LARC)
1 trial -
Temozolomide
PUMA BIOTECHNOLOGY, INC.
Glioblastoma
1 trial -
Temozolomide
The First People's Hospital of Lianyungang
Cytokine-Induced Killer Cells
1 trial -
silevertinib in combination with temozolomide
Blackmores Limited
Glioblastoma (GBM)
1 trial -
temozolomide
Universal Integrated
Cancer
1 trial -
temozolomide
Children's Hospital of Fudan University
Brain and Central Nervous System Tumors
1 trial -
Temozolomide
Monte Rosa Therapeutics
Brain Neoplasms, Malignant, Primary
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.